Scarica l'app Stockscreener
11.69
2.18%
-0.26
Dopo l'orario di chiusura:
11.77
0.08
+0.68%
Inogen Inc Borsa (INGN) Ultime notizie
Inogen's (INGN) "Hold" Rating Reiterated at Needham & Company LLC - MarketBeat
Investors in Inogen (NASDAQ:INGN) have unfortunately lost 75% over the last five years - Yahoo Finance UK
Inogen Stock Gains Following Solid Preliminary Q4 Revenues - MSN
Head-To-Head Analysis: Anteris Technologies Global (NASDAQ:AVR) vs. Inogen (NASDAQ:INGN) - Defense World
Terra Nexus, UAE Joins Inogen Alliance - Yahoo Finance
Inogen Stock May Gain on Deal With Yuwell to Expand Global Reach - Yahoo Finance
Tosyalı Launches one of the World’s Largest Self-Consumption Solar Power Plant Projects - GlobeNewswire Inc.
Inogen Announces Strategic Collaboration with Yuwell - MSN
Inogen partners with Yuwell to expand product portfolio, accelerate entry into Chinese market - Seeking Alpha
Arab Health 2025｜Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health - Morningstar
Inogen Secures $27.2M Strategic Partnership with Yuwell for Global Expansion - StockTitan
Assenagon Asset Management S.A. Has $683,000 Stock Holdings in Inogen, Inc. (NASDAQ:INGN) - MarketBeat
Assenagon Asset Management S.A. Sells 160,429 Shares of Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen, Inc. announced that it expects to receive $27.209763 million in funding -January 24, 2025 - Marketscreener.com
Inogen (INGN) Moves to Strong Buy: Rationale Behind the Upgrade - Yahoo Finance
Inogen, Inc. (NASDAQ:INGN) Held Back By Insufficient Growth Even After Shares Climb 32% - Simply Wall St
Inogen, Inc. (NASDAQ:INGN) Short Interest Down 6.2% in December - MarketBeat
Barclays PLC Purchases 23,398 Shares of Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen Insiders Benefitted From Selling Stock At US$8.56 - Simply Wall St
Inogen expects prelim Q4 revenue in the range of $79M to $80M - MSN
Inogen stock holds as revenue forecast beats consensus - Investing.com India
Inogen reports growth in Q4 and full year 2024 revenue By Investing.com - Investing.com Australia
Inogen stock holds as revenue forecast beats consensus By Investing.com - Investing.com Australia
Inogen (NASDAQ:INGN) Given "Hold" Rating at Needham & Company LLC - MarketBeat
Inogen, Inc. Provides Revenue Guidance for the Fourth Quarter of 2024 and Full Year 2024 - Marketscreener.com
Inogen, Inc. (NASDAQ:INGN) Stock Position Increased by JPMorgan Chase & Co. - Defense World
Inogen (NASDAQ:INGN) Stock Crosses Above Fifty Day Moving AverageHere's Why - MarketBeat
Inogen (NASDAQ:INGN) Stock Crosses Above Fifty Day Moving Average – Here’s Why - Defense World
Inogen reports growth in Q4 and full year 2024 revenue - Investing.com India
Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue - Business Wire
Inogen receives FDA 510(k) clearance for SIMEOX 200 airway clearance device - News-Medical.Net
Jane Street Group LLC Cuts Stake in Inogen, Inc. (NASDAQ:INGN) - Defense World
Jane Street Group LLC Sells 250,473 Shares of Inogen, Inc. (NASDAQ:INGN) - MarketBeat
Geode Capital Management LLC Purchases 5,921 Shares of Inogen, Inc. (NASDAQ:INGN) - Defense World
Franklin Resources Inc. Takes $139,000 Position in Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen, Inc. (NASDAQ:INGN) Shares Purchased by Barclays PLC - Defense World
FDA OKs Inogen’s Simeox 200 Airway Clearance Device - MPO-mag
Inogen Stock Rises as FDA Clears SIMEOX 200 Airway Clearance Device - MSN
Inogen Expands U.S. Market with FDA Clearance - Yahoo Finance
FDA grants clearance for Inogen’s SIMEOX 200 airway clearance device - Yahoo Finance
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device - BioSpace
Inogen Gets FDA Clearance for Airway Clearance Device - MarketWatch
Inogen, Inc. (NASDAQ:INGN) Shares Purchased by State Street Corp - Defense World
Inogen's SIMEOX 200 Airway Clearance Device Receives FDA Clearance for Chronic Lung Disease Treatment - StockTitan
Here's Why You Should Retain Inogen Stock in Your Portfolio Now - Nasdaq
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):